NDC 58468-0200 – Lemtrada

Alemtuzumab 12 mg/1.2mL · Injection, Solution, Concentrate · Intravenous

Human Prescription Drug

Product NDC58468-0200

Product details

Brand name
Lemtrada
Generic name
Alemtuzumab
Labeler
Genzyme Corporation
Dosage form
Injection, Solution, Concentrate
Route
Intravenous
Marketing category
BLA · BLA103948
Marketed since
November 18, 2014
Listing expires
December 31, 2026
Pharmacologic class
CD52-directed Cytolytic Antibody

Active ingredients

Uses, dosage, side effects and warnings for Lemtrada →

Package NDC codes (1)

Package NDCDescriptionSince
58468-0200-11 VIAL, SINGLE-USE in 1 CARTON (58468-0200-1) / 1.2 mL in 1 VIAL, SINGLE-USENov 18, 2014